Cardiome Pharma Corp (CRME.OQ)
20 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2015||Independent Chairman of the Board|
|52||2013||President, Chief Executive Officer, Director|
|45||2017||Chief Financial Officer|
|2013||Chief Operating Officer|
|2012||Corporate General Counsel|
- BRIEF-Cardiome Announces Amendment To Term Loan Agreement With CRG Managed Funds
- BRIEF-Cardiome Pharma - William Hunter, President & CEO, Justin Renz, CFO Purchased Total Of 210,000 Common Shares Of Co On TSX And Nasdaq On March 26
- BRIEF-Health Canada Accepts Cardiome's Xydalba For Review
- BRIEF-Cardiome Pharma To Pay $2.5 Mln Termination Fee To Cipher If Proposed Arrangement Not Completed
- BRIEF-Cipher Pharmaceuticals And Cardiome Pharma Announce Strategic Transaction For Canadian Business Portfolio Of Cardiome